Clinical use of intensity-modulated radiotherapy: Part II

British Journal of Radiology

Volumn 77, Issue 915, 2004, Pages 177-182

  Guerrero Urbano, M T ^a   Nutting, C M ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLADDER CANCER; BLADDER DISEASE; BONE MARROW DEPRESSION; BREAST CANCER; CANCER PATIENT; CARDIOTOXICITY; CLINICAL TRIAL; COMPUTER ASSISTED RADIOTHERAPY; DATA ANALYSIS; DOSIMETRY; ENTEROPATHY; ERECTILE DYSFUNCTION; ESOPHAGUS TUMOR; FEMALE; GASTROINTESTINAL TOXICITY; GYNECOLOGIC CANCER; HEMATOLOGIC DISEASE; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MALE; PANCREAS TUMOR; PELVIS LYMPH NODE; PROSTATE CANCER; RADIATION DOSE; RANDOMIZATION; RECTUM HEMORRHAGE; REVIEW; SECOND CANCER; SKIN TOXICITY; TREATMENT INDICATION; TREATMENT PLANNING; UROGENITAL TRACT DISEASE;

BREAST NEOPLASMS; FEMALE; GASTROINTESTINAL NEOPLASMS; GENITAL NEOPLASMS, FEMALE; HUMANS; MALE; NEOPLASMS; NEOPLASMS, SECOND PRIMARY; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; UROLOGIC NEOPLASMS;

EID: 1642441678     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/54028034     Document Type: Review

References (60)

1. Guerrero Urbano MT, Nutting CM. Clinical use of intensity modulated radiotherapy: Part I. Br J Radiol 2004;77:88-96.
2. Ling CC, Burman C, Chui CS, Kutcher GJ, Leibel SA, LoSasso T, et al. Conformal radiation treatment of prostate cancer using inversely-planned intensity-modulated photon beams produced with dynamic multileaf collimation. Int J Radiat Oncol Biol Phys 1996;35:721-30.
3. Stein J, Mohan R, Wang XH, Bortfeld T, Wu Q, Preiser K, et al. Number and orientations of beams in intensity-modulated radiation treatments. Med Phys 1997;24:149-60.
4. Burman C, Chui CS, Kutcher G, Leibel S, Zelefsky M, LoSasso T, et al. Planning, delivery, and quality assurance of intensity-modulated radiotherapy using dynamic multileaf collimator: A strategy for large-scale implementation for the treatment of carcinoma of the prostate. Int J Radiat Oncol Biol Phys 1997;39:863-73.
5. Zelefsky MJ, Fuks Z, Happersett L, Lee HJ, Ling CC, Burman CM, et al. Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer. Radiother Oncol 2000;55:241-9.
6. Zelefsky MJ, Fuks Z, Hunt M, Lee HJ, Lombardi D, Ling CC, et al. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. J Urol 2001;166:876-81.
7. Zelefsky MJ, Fuks Z, Hunt M, Yamada Y, Marion C, Ling CC, et al. High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients. Int J Radiat Oncol Biol Phys 2002;53:1111-6.
8. D'Amico, Chen M, Oh-Ung J, Renshaw AA, Cote K, Loffredo M, et al. Changing prostate specific antigen outcome after surgery or radiotherapy for localised prostate cancer during the prostate specific antigen era. Int J Radiat Oncol Biol Phys 2003;54:436-41.
9. De Meerleer GO, Vakaet LA, De Gersem WR, De Wagter C, De Naeyer B, De Neve W. Radiotherapy of prostate cancer with or without intensity modulated beams: A planning comparison. Int J Radiat Oncol Biol Phys 2000;47:639-48.
10. Kupelian PA, Reddy CA, Klein EA, Willoughby TR. Short-course intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: Preliminary results on late toxicity and quality of life. Int J Radiat Oncol Biol Phys 2001;51:988-93.
11. Bastasch MD, Teh BS, Mai WY, Carpenter LS, Lu HH, Chiu JK, et al. Post-nerve-sparing prostatectomy, dose-escalated intensity-modulated radiotherapy: Effect on erectile function. Int J Radiat Oncol Biol Phys 2002;54:101-6.
12. Nutting CM, Convery DJ, Cosgrove VP, Rowbottom C, Padhani AR, Webb S, et al. Reduction of small and large bowel irradiation using an optimized intensity-modulated pelvic radiotherapy technique in patients with prostate cancer. Int J Radiat Oncol Biol Phys 2000;48:649-56.
13. Clark CH, Mubata CD, Meehan CA, Bidmead AM, Staffurth J, Humphreys ME, et al. IMRT clinical implementation: Prostate and pelvic node irradiation using Helios and a 120-leaf multileaf collimator. J Appl Clin Med Phys 2002;3: 273-84.
14. Pickett B, Vigneault E, Kurhanewicz J, Verhey L, Roach M. Static field intensity modulation to treat a dominant intraprostatic lesion to 90 Gy compared to seven field 3-dimensional radiotherapy. Int J Radiat Oncol Biol Phys 1999;44:921-9.
15. Shu HK, Lee TT, Vigneauly E, Xia P, Pickett B, Phillips TL, et al. Toxicity following high-dose three-dimensional conformal and intensity-modulated radiation therapy for clinically localized prostate cancer. Urology 2001;57:102-7.
16. Nutting CM, Corbishley CM, Sanchez-Nieto B, Cosgrove VP, Webb S, Dearnaley DP. Potential improvements in the therapeutic ratio of prostate cancer irradiation: Dose escalation of pathologically identified tumour nodules using intensity modulated radiotherapy. Br J Radiol 2002;75: 151-61.
17. Budgell GJ, Mott JH, Logue JP, Hounsell AR. Clinical implementation of dynamic multileaf collimation for compensated bladder treatments. Radiother Oncol 2001;59:31-8.
18. Muren LP, Hafslund R, Gustafsson A, Smaaland R, Dahl O. Partially wedged beams improve radiotherapy treatment of urinary bladder cancer. Radiother Oncol 2001;59:21-30.
19. Low DA, Grigsby PW, Dempsey JF, Mutic S, Williamson JF, Markman J, et al. Applicator-guided intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 2002;52: 1400-6.
20. Portelance L, Chao KS, Grigsby PW, Bennet H, Low D. Intensity-modulated radiation therapy (IMRT) reduces small bowel, rectum, and bladder doses in patients with cervical cancer receiving pelvic and para-aortic irradiation. Int J Radiat Oncol Biol Phys 2001;51:261-6.
21. Roeske JC, Lujan A, Rotmensch J, Waggoner SE, Yamada D, Mundt AJ. Intensity modulated whole pelvic radiation therapy in patients with gynecologic malignancies. Int J Radiat Oncol Biol Phys 2000;48:1613-21.
22. Mutic S, Malyapa RS, Grigsby PW, Dehdashti F, Miller TR, Zoberi I, et al. PET-guided IMRT for cervical carcinoma with positive para-aortic lymph nodes-a dose-escalation treatment planning study. Int J Radiat Oncol Biol Phys 2003;55:28-35.
23. Aoki T, Nagata Y, Mizowaki T, Kokubo M, Negoro Y, Takayama K, et al. Clinical evaluation of dynamic arc conformal radiotherapy for paraaortic lymph node metastasis. Radiother Oncol 2003;67:113-8.
24. Hong L, Alektiar K, Chui C, LoSasso T, Hunt M, Spirou S, et al. IMRT of large fields: Whole-abdomen irradiation. Int J Radiat Oncol Biol Phys 2002;54:278-89.
25. Mundt AJ, Roeske JC, Lujan AE, Yamada SD, Waggoner SE, Fleming G, et al. Initial clinical experience with intensity-modulated whole-pelvis radiation therapy in women with gynecologic malignancies. Gynecol Oncol 2001;82:456-63.
26. Mundt AJ, Lujan AE, Rotmensch J, Waggoner SE, Yamada SD, Fleming G, et al. Intensity-modulated whole pelvic radiotherapy in women with gynecologic malignancies. Int J Radiat Oncol Biol Phys 2002;52:1330-7.
27. Brixey CJ, Roeske JC, Lujan AE, Yamada SD, Rotmensch J, Mundt AJ. Impact of intensity-modulated radiotherapy on acute hematologic toxicity in women with gynecologic malignancies. Int J Radiat Oncol Biol Phys 2002;54:1388-96.
28. Chao KS, Lin M. Lymphangiogram-assisted lymph node target delineation for patients with gynecologic malignancies. Int J Radiat Oncol Biol Phys 2002;54:1147-52.
29. Nutting CM, Bedford JL, Cosgrove VP, Tait DM, Dearnaley DP, Webb S. Intensity-modulated radiotherapy reduces lung irradiation in patients with carcinoma of the oesophagus. Front Radiat Ther Oncol 2002;37:128-31.
30. Zurlo A, Lomax A, Hoess A, Bortfeld T, Russo M, Goitein G, et al. The role of proton therapy in the treatment of large irradiation volumes: A comparative planning study of pancreatic and biliary tumors. Int J Radiat Oncol Biol Phys 2000;48:277-88.
31. Landry JC, Yang GY, Ting JY, Staley CA, Torres W, Esiashvili N, et al. Treatment of pancreatic cancer tumors with intensity-modulated radiation therapy (IMRT) using the volume at risk approach (VARA): employing dose-volume histogram (DVH) and normal tissue complication probability (NTCP) to evaluate small bowel toxicity. Med Dosim 2002;27:121-9.
32. Crane CH, Mason K, Janjan NA, Milas L. Initial experience combining cyclooxygenase-2 inhibition with chemoradiation for locally advanced pancreatic cancer. Am J Clin Oncol 2003;26:S81-4.
33. Dorr W, Herrmann T. Cancer induction by radiotherapy: Dose dependence and spatial relationship to irradiated volume. J Radiol Prot 2002;22:A117-21.
34. Verellen D, Vanhavere F. Risk assessment of radiation-induced malignancies based on whole-body equivalent dose estimates for IMRT treatment in the head and neck region. Radiother Oncol 1999;53:199-203.
35. Hall EJ, Wuu CS. Radiation-induced second cancers: The impact of 3D-CRT and IMRT. Int J Radiat Oncol Biol Phys 2003;56:83-8.
36. Favourable, unfavourable effects on long-term survival of radiotherapy for early breast cancer, an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group. Lancet 2000;355:1757-70.
37. Overgaard M, Christensen JJ, Johansen H, Nybo-Rasmussen A, Rose C, van der Kooy P, et al. Evaluation of radiotherapy in high-risk breast cancer patients: Report from the Danish Breast Cancer Cooperative Group (DBCG 82) Trial. Int J Radiat Oncol Biol Phys 1990;19:1121-4.
38. Overgaard M, Jensen MB, Overgaard J, Hansen PS, Rose C, Andersson M, et al. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet 1999;353:1641-8.
39. Ragaz J, Jackson SM, Le N, Plenderleith IH, Spinelli JJ, Basco VE, et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 1997;337:956-62.
40. Hojris I, Overgaard M, Christensen JJ, Overgaard J. Morbidity and mortality of ischaemic heart disease in high-risk breast-cancer patients after adjuvant postmastectomy systemic treatment with or without radiotherapy: Analysis of DBCG 82b and 82c randomised trials. Radiotherapy Committee of the Danish Breast Cancer Cooperative Group. Lancet 1999;354:1425-30.
41. Woodward WA, Strom EA, McNeese MD, Perkins GH, Outlaw EL, Hortobagyi GN, et al. Cardiovascular death and second non-breast cancer malignancy after postmastectomy radiation and doxorubicin-based chemotherapy. Int J Radiat Oncol Biol Phys 2003;57:327-35.
42. Neal AJ, Torr M, Helyer S, Yarnold JR. Correlation of breast dose heterogeneity with breast size using 3D CT planning and dose-volume histograms. Radiother Oncol 1995;34:210-8.
43. Evans PM, Hansen VN, Mayles WP, Swindell W, Torr M, Yarnold JR. Design of compensators for breast radiotherapy using electronic portal imaging. Radiother Oncol 1995;37: 43-54.
44. Evans PM, Donovan EM, Fenton N, Hansen VN, Moore I, Partridge M, et al. Practical implementation of compensators in breast radiotherapy. Radiother Oncol 1998;49:255-65.
45. Evans PM, Donovan EM, Partridge M, Childs PJ, Convery DJ, Eagle S, et al. The delivery of intensity modulated radiotherapy to the breast using multiple static fields. Radiother Oncol 2000;57:79-89.
46. Donovan EM, Johnson U, Shentall G, Evans PM, Neal AJ, Yarnold JR. Evaluation of compensation in breast radiotherapy: A planning study using multiple static fields. Int J Radiat Oncol Biol Phys 2000;46:671-9.
47. Hong L, Hunt M, Chui C, Spirou S, Forster K, Lee H, et al. Intensity-modulated tangential beam irradiation of the intact breast. Int J Radiat Oncol Biol Phys 1999;44:1155-64.
48. Li JG, Williams SS, Goffinet DR, Boyer AL, Xing L. Breast-conserving radiation therapy using combined electron and intensity-modulated radiotherapy technique. Radiother Oncol 2000;56:65-71.
49. Lo YC, Yasuda G, Fitzgerald TJ, Urie MM. Intensity modulation for breast treatment using static multi-leaf collimators. Int J Radiat Oncol Biol Phys 2000;46:187-94.
50. Kestin LL, Sharpe MB, Frazier RC, Vicini FA, Yan D, Matter RC, et al. Intensity modulation to improve dose uniformity with tangential breast radiotherapy: Initial clinical experience. Int J Radiat Oncol Biol Phys 2000;48:1559-68.
51. Chui CS, Spirou SV. Inverse planning algorithms for external beam radiation therapy. Med Dosim 2001;26:189-97.
52. Landau D, Adams EJ, Webb S, Ross G. Cardiac avoidance in breast radiotherapy: A comparison of simple shielding techniques with intensity-modulated radiotherapy. Radiother Oncol 2001;60:247-55.
53. Stemmer SM, Rizel S, Hardan I, Adamo A, Neumann A, Goffman J, et al. The role of irradiation of the internal mammary lymph nodes in high-risk stage II to IIIA breast cancer patients after high-dose chemotherapy: A prospective sequential nonrandomized study. J Clin Oncol 2003;21: 2713-8.
54. Remouchamps VM, Letts N, Vicini FA, Sharpe MB, Kestin LL, Chen PY, et al. Initial clinical experience with moderate deep-inspiration breath hold using an active breathing control device in the treatment of patients with left-sided breast cancer using external beam radiation therapy. Int J Radiat Oncol Biol Phys 2003;56:704-15.
55. Krueger EA, Fraass BA, McShan DL, Marsh R, Pierce LJ. Potential gains for irradiation of chest wall and regional nodes with intensity modulated radiotherapy. Int J Radiat Oncol Biol Phys 2003;56:1023-37.
56. Hurkmans CW, Cho BC, Damen E, Zijp L, Mijnheer BJ. Reduction of cardiac and lung complication probabilities after breast irradiation using conformal radiotherapy with or without intensity modulation. Radiother Oncol 2002;62: 163-71.
57. Vicini FA, Sharpe M, Kestin L, Martinez A, Mitchell CK, Wallace MF, et al. Optimizing breast cancer treatment efficacy with intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 2002;54:1336-44.
58. Yarnold JR, Donovan EM, Reise S, et al. Randomised trial of standard 2D radiotherapy versus 3D intensity modulated radiotherapy in patients prescribed breast radiotherapy. Radiother Oncol 2002;65:(S15)64.
59. Donovan EM, Bleackley NJ, Evans PM, Reise SF, Yarnold JR. Dose-position and dose-volume histogram analysis of standard wedged and intensity modulated treatments in breast radiotherapy. Br J Radiol 2002;75:967-73.
60. Teh BS, Lu HH, Sobremonte S, Bellezza D, Chiu JK, Carpenter LS, et al. The potential use of intensity modulated radiotherapy (IMRT) in women with pectus excavatum desiring breast-conserving therapy. Breast J 2001;7:233-9.